ArriVent BioPharma Inc
AVBP
NASDAQ
Biotechnology
$29.51
USD
-0.49 (-1.63%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.44B
Volume 439.0K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
TRAX | First Tracks Biotherapeutics Inc | $1.67B | - | - | - | |
FBRX | Forte Biosciences Inc | $1.57B | - | -99.8% | - | |
ABSI | Absci Corp | $1.53B | - | -61.9% | - | |
VIR | Vir Biotechnology Inc | $1.49B | - | +1496.1% | - | |
AVBP | ArriVent BioPharma Inc | $1.44B | - | - | - | |
ORIC | Oric Pharmaceuticals Inc | $1.42B | - | - | - | |
GLUE | Monte Rosa Therapeutics Inc | $1.35B | - | -83.9% | - | |
AKTS | Aktis Oncology Inc | $1.33B | - | +49.9% | - | |
PURR | Hyperliquid Strategies Inc | $1.32B | - | - | - | |
JBIO | Jade Biosciences Inc | $1.32B | - | - | - | |
MNKD | MannKind Corp | $1.29B | - | +30.5% | - |
Top Peer by Growth
Vir Biotechnology Inc
+1496.1% YoY Revenue
Best 1-Year Return
Monte Rosa Therapeutics Inc
+258.4% Return